LON:SONG

Hipgnosis Songs Fund Share Forecast, Price & News

GBX 120.64
+0.04 (+0.03 %)
(As of 07/28/2021 08:02 AM ET)
Add
Compare
Today's Range
120.40
120.64
50-Day Range
120.20
124.80
52-Week Range
114
129.90
Volume3,014 shs
Average Volume2.08 million shs
Market Capitalization£1.31 billion
P/E Ratio2,566.72
Dividend Yield4.35%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SONG News and Ratings via Email

Sign-up to receive the latest news and ratings for Hipgnosis Songs Fund and its competitors with MarketBeat's FREE daily newsletter.


Hipgnosis Songs Fund logo

About Hipgnosis Songs Fund

Hipgnosis Songs Fund Limited is a closed-ended fund launched and managed by The Family (Music) Limited. The fund invests in songs and associated musical intellectual property rights, including master recordings and producer royalties. Hipgnosis Songs Fund Limited was formed in 2018 and is domiciled in Guernsey.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.75 out of 5 stars

Analyst Opinion: 1.5Community Rank: 3.3Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Hipgnosis Songs Fund (LON:SONG) Frequently Asked Questions

Is Hipgnosis Songs Fund a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hipgnosis Songs Fund in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Hipgnosis Songs Fund stock.
View analyst ratings for Hipgnosis Songs Fund
or view top-rated stocks.

What stocks does MarketBeat like better than Hipgnosis Songs Fund?

Wall Street analysts have given Hipgnosis Songs Fund a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Hipgnosis Songs Fund wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Hipgnosis Songs Fund's stock been impacted by Coronavirus (COVID-19)?

Hipgnosis Songs Fund's stock was trading at GBX 101 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SONG shares have increased by 19.4% and is now trading at GBX 120.60.
View which stocks have been most impacted by COVID-19
.

How often does Hipgnosis Songs Fund pay dividends? What is the dividend yield for Hipgnosis Songs Fund?

Hipgnosis Songs Fund announced a dividend on Tuesday, July 20th. Shareholders of record on Thursday, July 29th will be given a dividend of GBX 1.31 per share on Tuesday, August 31st. This represents a dividend yield of 1.09%. The ex-dividend date of this dividend is Thursday, July 29th. The official announcement can be accessed at this link.
View Hipgnosis Songs Fund's dividend history
.

Is Hipgnosis Songs Fund a good dividend stock?

Hipgnosis Songs Fund pays an annual dividend of GBX 0.05 per share and currently has a dividend yield of 4.35%. SONG has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of Hipgnosis Songs Fund is 106.38%. Payout ratios above 75% are not desirable because they may not be sustainable.
View Hipgnosis Songs Fund's dividend history.

What price target have analysts set for SONG?

1 equities research analysts have issued 12-month target prices for Hipgnosis Songs Fund's shares. Their forecasts range from GBX 130 to GBX 130. On average, they anticipate Hipgnosis Songs Fund's stock price to reach GBX 130 in the next twelve months. This suggests a possible upside of 7.8% from the stock's current price.
View analysts' price targets for Hipgnosis Songs Fund
or view top-rated stocks among Wall Street analysts.

Who are Hipgnosis Songs Fund's key executives?

Hipgnosis Songs Fund's management team includes the following people:
  • Mr. Merck Mercuriadis, Founder & CEO of The Family (Music) Limited (Age 58)
  • Mr. Ted Cockle, Pres
  • Mr. Chris Helm, Chief Financial Officer of The Family (Music) Limited
  • Mr. Bjorn Lindvall, Chief Operations Officer
  • Ms. Amy Thompson, Chief Catalogue Officer

Who are some of Hipgnosis Songs Fund's key competitors?

What other stocks do shareholders of Hipgnosis Songs Fund own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hipgnosis Songs Fund investors own include Analog Devices (ADI), (CNMD), Walmart (WMT), Banco BBVA Argentina (BBAR), Basic Energy Services (BAS), Bank of America (BAC), AXT (AXTI), American Express (AXP), Broadcom (AVGO) and ASGN (ASGN).

What is Hipgnosis Songs Fund's stock symbol?

Hipgnosis Songs Fund trades on the London Stock Exchange (LON) under the ticker symbol "SONG."

How do I buy shares of Hipgnosis Songs Fund?

Shares of SONG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Hipgnosis Songs Fund's stock price today?

One share of SONG stock can currently be purchased for approximately GBX 120.60.

How much money does Hipgnosis Songs Fund make?

Hipgnosis Songs Fund has a market capitalization of £1.31 billion and generates £138.39 million in revenue each year.

What is Hipgnosis Songs Fund's official website?

The official website for Hipgnosis Songs Fund is www.hipgnosissongs.com.


This page was last updated on 7/28/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.